Free Trial

Incyte (INCY) Financials

Incyte logo
$65.35 +1.10 (+1.71%)
Closing price 04:00 PM Eastern
Extended Trading
$65.48 +0.13 (+0.20%)
As of 04:28 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Incyte

Annual Income Statements for Incyte

This table shows Incyte's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Income / (Loss) Attributable to Common Shareholders
33 598 341 949 -296 447 109 -313 104 6.53
Consolidated Net Income / (Loss)
33 598 341 949 -296 447 109 -313 104 6.53
Net Income / (Loss) Continuing Operations
33 598 341 949 -296 447 109 -313 104 6.53
Total Pre-Tax Income
317 834 529 570 -232 487 115 -312 107 7.56
Total Operating Income
61 621 579 586 -264 402 129 -243 145 51
Total Gross Profit
3,929 3,441 3,188 2,835 2,535 2,045 1,788 1,457 1,048 727
Total Revenue
4,241 3,696 3,395 2,986 2,667 2,159 1,882 1,536 1,106 754
Operating Revenue
4,241 3,696 3,395 2,986 2,667 2,159 1,882 1,536 1,106 754
Total Cost of Revenue
312 255 207 151 131 114 94 79 58 27
Operating Cost of Revenue
312 255 207 151 131 114 94 79 58 27
Total Operating Expenses
3,868 2,820 2,608 2,249 2,799 1,643 1,659 1,700 903 676
Selling, General & Admin Expense
1,242 1,161 1,002 740 517 469 434 366 303 197
Research & Development Expense
2,607 1,628 1,586 1,458 2,216 1,154 1,198 1,326 582 480
Other Operating Expenses / (Income)
-1.03 2.05 7.97 37 43 0.00 0.00 - - -
Other Special Charges / (Income)
20 29 12 15 23 20 26 7.70 17 0.00
Total Other Income / (Expense), net
255 214 -50 -15 31 85 -14 -69 -38 -43
Interest Expense
2.28 2.55 2.67 1.91 2.17 1.86 1.54 62 39 46
Interest & Investment Income
245 202 40 -24 10 34 -44 -24 1.15 7.09
Other Income / (Expense), net
13 14 -88 11 23 52 32 17 - -4.58
Income Tax Expense
284 237 188 -378 63 40 5.85 0.85 3.18 1.03
Basic Earnings per Share
$0.16 $2.67 $1.53 $4.30 ($1.36) $2.08 $0.52 ($1.53) $0.55 $0.04
Weighted Average Basic Shares Outstanding
207.11M 223.63M 222.00M 220.43M 218.07M 214.91M 212.38M 204.58M 187.87M 179.60M
Diluted Earnings per Share
$0.15 $2.65 $1.52 $4.27 ($1.36) $2.05 $0.51 ($1.53) $0.54 $0.03
Weighted Average Diluted Shares Outstanding
210.53M 225.93M 223.96M 222.07M 218.07M 217.66M 215.64M 204.58M 194.13M 187.30M
Weighted Average Basic & Diluted Shares Outstanding
193.52M 224.53M 222.97M 221.33M 219.84M 216.78M 210.60M 204.70M 189.50M 163.30M

Quarterly Income Statements for Incyte

This table shows Incyte's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
158 201 106 -445 170 201 171 204 22 28 113
Consolidated Net Income / (Loss)
158 201 106 -445 170 201 171 204 22 28 113
Net Income / (Loss) Continuing Operations
158 201 106 -445 170 201 171 204 22 28 113
Total Pre-Tax Income
234 314 157 -390 236 271 234 278 52 81 149
Total Operating Income
205 302 146 -478 92 187 215 194 25 70 138
Total Gross Profit
980 1,090 1,052 967 820 944 859 886 752 868 769
Total Revenue
1,053 1,179 1,138 1,044 881 1,013 919 955 809 927 823
Operating Revenue
1,053 1,179 1,138 1,044 881 1,013 919 955 809 927 823
Total Cost of Revenue
73 88 86 77 61 70 60 68 57 59 55
Operating Cost of Revenue
73 88 86 77 61 70 60 68 57 59 55
Total Operating Expenses
775 789 906 1,445 728 756 644 693 727 797 630
Selling, General & Admin Expense
326 327 309 306 300 294 268 284 316 273 266
Research & Development Expense
437 466 573 1,138 429 444 376 401 407 501 384
Other Operating Expenses / (Income)
0.00 - 0.00 0.00 -1.03 2.90 1.05 -0.55 -1.36 -1.08 1.77
Other Special Charges / (Income)
12 -4.04 23 0.89 -0.46 15 -0.43 8.37 6.20 24 -22
Total Other Income / (Expense), net
29 12 10 88 144 84 19 84 27 11 10
Interest Expense
0.66 0.42 0.77 0.66 0.43 0.80 0.62 0.66 0.47 0.67 0.64
Interest & Investment Income
22 119 -13 39 100 192 -27 42 -5.32 113 -0.66
Other Income / (Expense), net
8.10 -106 24 50 45 -108 46 43 33 -101 12
Income Tax Expense
76 113 50 55 67 70 63 74 30 52 36
Basic Earnings per Share
$0.82 $0.89 $0.55 ($2.04) $0.76 $0.90 $0.76 $0.91 $0.10 $0.12 $0.51
Weighted Average Basic Shares Outstanding
193.71M 207.11M 192.63M 218.18M 224.48M 223.63M 224.08M 223.25M 222.96M 222.00M 222.42M
Diluted Earnings per Share
$0.80 $0.90 $0.54 ($2.04) $0.75 $0.89 $0.76 $0.90 $0.10 $0.13 $0.50
Weighted Average Diluted Shares Outstanding
198.20M 210.53M 195.84M 218.18M 227.22M 225.93M 226.17M 225.65M 225.59M 223.96M 224.18M
Weighted Average Basic & Diluted Shares Outstanding
193.57M 193.52M 192.65M 192.60M 224.54M 224.53M 224.11M 224.09M 223.09M 222.97M 222.48M

Annual Cash Flow Statements for Incyte

This table details how cash moves in and out of Incyte's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Net Change in Cash & Equivalents
-1,526 262 894 544 -319 669 264 247 117 69
Net Cash From Operating Activities
335 496 970 749 -125 711 336 -93 305 89
Net Cash From Continuing Operating Activities
335 496 970 749 -125 711 336 -93 317 89
Net Income / (Loss) Continuing Operations
33 598 341 949 -296 447 109 -313 104 6.53
Consolidated Net Income / (Loss)
33 598 341 949 -296 447 109 -313 104 6.53
Depreciation Expense
89 83 68 58 52 55 55 52 58 45
Non-Cash Adjustments To Reconcile Net Income
141 195 293 208 168 133 193 225 100 73
Changes in Operating Assets and Liabilities, net
72 -378 268 -465 -49 77 -21 -57 55 -35
Net Cash From Investing Activities
158 -208 -79 -208 -269 -87 -86 -350 -232 -105
Net Cash From Continuing Investing Activities
158 -208 -79 -208 -269 -87 -86 -350 -232 -105
Purchase of Property, Plant & Equipment
-86 -32 -78 -181 -187 -78 -73 -111 -120 -26
Acquisitions
-14 -15 0.00 0.00 - - - - -143 0.00
Purchase of Investments
-258 -466 -80 -269 -612 -375 -169 -385 -57 -148
Sale and/or Maturity of Investments
516 306 79 242 531 365 156 146 88 69
Net Cash From Financing Activities
-2,022 -20 -0.79 6.18 72 46 15 690 45 85
Net Cash From Continuing Financing Activities
-2,022 -20 -0.79 6.18 72 46 15 690 45 85
Repurchase of Common Equity
-2,005 0.00 0.00 - - - - - - -
Issuance of Common Equity
49 36 61 59 133 80 30 716 50 86
Other Financing Activities, net
-66 -56 -62 -52 -61 -34 -15 -17 -4.91 0.00
Effect of Exchange Rate Changes
2.92 -6.68 3.36 -3.57 - - - - -0.01 0.00
Cash Income Taxes Paid
373 378 136 68 71 34 5.42 6.31 0.93 0.06

Quarterly Cash Flow Statements for Incyte

This table details how cash moves in and out of Incyte's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
254 384 317 -2,359 133 -14 96 310 -130 261 255
Net Cash From Operating Activities
266 381 311 -576 219 148 148 307 -106 284 296
Net Cash From Continuing Operating Activities
266 381 311 -576 219 148 148 307 -106 284 296
Net Income / (Loss) Continuing Operations
158 201 106 -445 170 201 171 204 22 28 113
Consolidated Net Income / (Loss)
158 201 106 -445 170 201 171 204 22 28 113
Depreciation Expense
22 23 23 22 22 22 21 20 19 18 17
Non-Cash Adjustments To Reconcile Net Income
68 78 83 17 -37 49 78 12 56 30 61
Changes in Operating Assets and Liabilities, net
18 80 98 -170 65 -124 -123 71 -203 207 106
Net Cash From Investing Activities
1.10 -21 38 214 -73 -155 -17 -7.43 -29 -21 -28
Net Cash From Continuing Investing Activities
1.10 -21 38 214 -73 -155 -17 -7.43 -29 -21 -28
Purchase of Property, Plant & Equipment
-3.17 -17 -5.19 -54 -9.55 -2.27 -11 -7.34 -12 -21 -28
Purchase of Investments
-41 -29 -25 -38 -166 -234 -80 -97 -55 -21 -15
Sale and/or Maturity of Investments
46 25 81 308 102 82 74 97 53 21 14
Net Cash From Financing Activities
-13 20 -32 -1,997 -12 0.35 -37 13 4.01 -2.48 -14
Net Cash From Continuing Financing Activities
-13 20 -32 -1,997 -12 0.35 -37 13 4.01 -2.48 -14
Issuance of Common Equity
3.24 33 1.28 14 0.48 7.52 -0.05 14 14 18 5.30
Other Financing Activities, net
-16 -13 -34 -6.97 -13 -7.17 -37 -1.51 -9.98 -21 -20
Effect of Exchange Rate Changes
-0.55 3.46 0.13 0.01 -0.68 -7.30 2.72 -1.89 -0.20 0.63 1.53
Cash Income Taxes Paid
0.84 70 73 227 2.69 125 116 130 7.11 20 40

Annual Balance Sheets for Incyte

This table presents Incyte's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Total Assets
5,444 6,782 5,841 4,933 3,561 3,427 2,646 2,303 1,639 1,007
Total Current Assets
3,239 4,645 4,093 3,119 2,360 2,481 1,832 1,505 994 842
Cash & Equivalents
1,688 3,213 2,951 2,057 1,513 1,833 1,164 900 652 521
Short-Term Investments
470 - 288 291 288 285 274 270 156 186
Accounts Receivable
853 744 645 616 482 309 308 266 149 114
Inventories, net
59 63 42 28 16 11 6.97 6.48 4.11 1.78
Prepaid Expenses
169 183 167 126 60 44 79 62 33 18
Plant, Property, & Equipment, net
763 752 739 724 560 378 320 260 168 86
Total Noncurrent Assets
1,442 1,385 1,009 1,091 639 568 494 538 477 79
Long-Term Investments
19 188 134 221 224 135 100 135 33 49
Noncurrent Note & Lease Receivables
31 26 26 28 28 29 - - - -
Goodwill
156 156 156 156 156 156 156 156 156 0.00
Intangible Assets
114 124 129 151 172 194 215 237 258 0.00
Noncurrent Deferred & Refundable Income Taxes
762 632 458 468 - - - - - -
Other Noncurrent Operating Assets
361 261 106 68 59 55 23 10 30 30
Total Liabilities & Shareholders' Equity
5,444 6,782 5,841 4,933 3,561 3,427 2,646 2,303 1,639 1,007
Total Liabilities
1,997 1,592 1,471 1,163 950 828 720 672 1,219 836
Total Current Liabilities
1,642 1,240 1,157 854 631 513 425 375 274 168
Short-Term Debt
39 38 37 37 38 52 32 34 20 0.00
Accounts Payable
197 110 278 172 99 84 104 68 76 30
Accrued Expenses
1,212 936 701 534 378 286 229 199 127 87
Current Employee Benefit Liabilities
189 153 139 109 113 91 60 75 51 38
Other Current Liabilities
4.42 3.44 3.18 2.64 2.28 0.66 - - - -
Total Noncurrent Liabilities
355 352 314 309 318 315 295 297 946 668
Other Noncurrent Operating Liabilities
355 352 314 309 318 315 277 280 294 48
Total Equity & Noncontrolling Interests
3,448 5,190 4,370 3,770 2,611 2,598 1,926 1,631 419 171
Total Preferred & Common Equity
3,448 5,190 4,370 3,770 2,611 2,598 1,926 1,631 419 171
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
3,448 5,190 4,370 3,770 2,611 2,598 1,926 1,631 419 171
Common Stock
4,534 5,016 4,792 4,567 4,353 4,045 3,814 3,628 2,097 1,951
Retained Earnings
-1,073 160 -437 -778 -1,726 -1,431 -1,878 -1,990 -1,675 -1,779
Accumulated Other Comprehensive Income / (Loss)
-13 13 15 -19 -15 -16 -10 -7.01 -2.89 -0.81
Other Equity Adjustments
0.00 0.00 0.00 0.00 0.00 0.00 - - - -

Quarterly Balance Sheets for Incyte

This table presents Incyte's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Total Assets
5,749 5,444 5,012 4,662 7,136 6,782 6,388 6,208 5,798 5,841 5,510
Total Current Assets
3,507 3,239 2,809 2,567 4,849 4,645 4,403 4,264 3,972 4,093 3,821
Cash & Equivalents
1,942 1,688 1,304 987 3,346 3,213 3,227 3,131 2,821 2,951 2,691
Short-Term Investments
467 470 471 532 504 - 289 292 292 288 287
Accounts Receivable
823 853 758 739 746 744 657 638 624 645 618
Inventories, net
64 59 70 101 64 63 57 36 41 42 46
Prepaid Expenses
212 169 205 208 189 183 172 167 194 167 180
Plant, Property, & Equipment, net
765 763 773 762 720 752 733 749 742 739 716
Total Noncurrent Assets
1,477 1,442 1,431 1,333 1,567 1,385 1,253 1,194 1,084 1,009 973
Long-Term Investments
17 19 28 30 288 188 154 170 128 134 151
Noncurrent Note & Lease Receivables
30 31 25 26 26 26 25 26 26 26 27
Goodwill
156 156 156 156 156 156 156 156 156 156 156
Intangible Assets
108 114 120 114 118 124 129 135 141 129 135
Noncurrent Deferred & Refundable Income Taxes
769 762 762 730 667 632 564 533 495 458 427
Other Noncurrent Operating Assets
397 361 340 279 313 261 225 175 139 106 79
Total Liabilities & Shareholders' Equity
5,749 5,444 5,012 4,662 7,136 6,782 6,388 6,208 5,798 5,841 5,510
Total Liabilities
2,082 1,997 1,841 1,665 1,741 1,592 1,457 1,468 1,335 1,471 1,284
Total Current Liabilities
1,720 1,642 1,502 1,337 1,396 1,240 1,125 1,119 1,006 1,157 1,007
Short-Term Debt
42 39 40 37 37 38 37 38 37 37 34
Accounts Payable
196 197 179 148 164 110 139 156 56 278 163
Accrued Expenses
1,376 1,212 1,128 1,034 1,102 936 821 811 825 701 700
Current Employee Benefit Liabilities
103 189 151 114 89 153 125 112 85 139 106
Other Current Liabilities
4.48 4.42 3.93 3.87 3.68 3.44 3.06 3.17 3.15 3.18 3.11
Total Noncurrent Liabilities
362 355 340 328 345 352 332 349 329 314 277
Capital Lease Obligations
33 - 28 - 29 - 29 - 30 - 30
Other Noncurrent Operating Liabilities
329 355 311 328 316 352 303 349 299 314 246
Commitments & Contingencies
0.00 - 0.00 0.00 0.00 - 0.00 - - - -
Total Equity & Noncontrolling Interests
3,668 3,448 3,171 2,997 5,394 5,190 4,931 4,741 4,463 4,370 4,227
Total Preferred & Common Equity
3,668 3,448 3,171 2,997 5,394 5,190 4,931 4,741 4,463 4,370 4,227
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
3,668 3,448 3,171 2,997 5,394 5,190 4,931 4,741 4,463 4,370 4,227
Common Stock
4,588 4,534 4,430 4,383 5,071 5,016 4,949 4,926 4,857 4,792 4,721
Retained Earnings
-915 -1,073 -1,274 -1,380 330 160 -41 -212 -416 -437 -466
Accumulated Other Comprehensive Income / (Loss)
-6.24 -13 16 -5.42 -6.17 13 23 27 21 15 -29

Annual Metrics And Ratios for Incyte

This table displays calculated financial ratios and metrics derived from Incyte's official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015
Growth Metrics
- - - - - - - - - -
Revenue Growth
14.76% 8.87% 13.67% 11.98% 23.53% 14.71% 22.50% 38.93% 46.70% 47.36%
EBITDA Growth
-77.21% 28.24% -14.53% 446.79% -137.09% 135.57% 224.07% -185.56% 123.66% 148.44%
EBIT Growth
-88.31% 29.13% -17.62% 348.02% -152.95% 182.13% 171.16% -256.03% 214.73% 1,058.99%
NOPAT Growth
-98.58% 19.16% -61.70% 627.75% -150.01% 200.88% 172.00% -221.09% 221.38% 1,401.89%
Net Income Growth
-94.54% 75.42% -64.09% 420.79% -166.17% 308.16% 134.97% -400.46% 1,495.80% 113.47%
EPS Growth
-94.34% 74.34% -64.40% 413.97% -166.34% 301.96% 133.33% -383.33% 1,700.00% 110.34%
Operating Cash Flow Growth
-32.46% -48.81% 29.41% 701.52% -117.53% 111.36% 461.58% -130.51% 240.86% 2.08%
Free Cash Flow Firm Growth
250.17% -160.46% 60.74% 187.87% -200.23% 551.64% 121.04% -297.01% -656.82% 73.71%
Invested Capital Growth
-28.31% 76.71% -16.45% 98.91% 56.12% -8.75% 15.98% 50.74% 628.66% 276.89%
Revenue Q/Q Growth
4.06% 2.40% 1.92% 2.52% 8.55% 2.42% 4.69% 8.29% 8.08% 18.92%
EBITDA Q/Q Growth
-20.10% -1.90% -20.52% -7.22% 23.52% 3.40% 4,753.14% -1,349.74% -15.06% 1,311.22%
EBIT Q/Q Growth
-36.20% -2.68% -23.12% -8.10% 19.48% 4.03% 376.40% -228.39% -22.89% 215.02%
NOPAT Q/Q Growth
200.79% 33.80% -60.96% 76.30% 20.79% 1.10% 305.75% -253.29% -14.51% 256.14%
Net Income Q/Q Growth
0.41% 40.62% -61.11% 77.44% 11.61% 10.36% 200.27% -102.50% -30.76% 107.63%
EPS Q/Q Growth
7.14% 40.21% -61.32% 74.29% 13.38% 10.22% 204.08% -91.25% -32.50% 106.38%
Operating Cash Flow Q/Q Growth
229.25% -21.49% 21.00% 139.10% -138.02% 7.21% 106.12% -202.57% 36.47% -51.02%
Free Cash Flow Firm Q/Q Growth
548.26% -306.67% 15.08% 329.19% -396.40% 15.02% 196.31% -108.51% -8.32% -81.67%
Invested Capital Q/Q Growth
-8.87% 37.69% -11.13% 74.54% 0.00% 7.49% 21.37% 6.21% -4.01% 28.90%
Profitability Metrics
- - - - - - - - - -
Gross Margin
92.64% 93.10% 93.90% 94.94% 95.08% 94.71% 95.00% 94.83% 94.74% 96.42%
EBITDA Margin
3.85% 19.40% 16.47% 21.91% -7.07% 23.57% 11.48% -11.33% 18.40% 12.07%
Operating Margin
1.45% 16.79% 17.07% 19.62% -9.89% 18.62% 6.87% -15.84% 13.11% 6.72%
EBIT Margin
1.75% 17.17% 14.47% 19.97% -9.02% 21.04% 8.55% -14.73% 13.11% 6.11%
Profit (Net Income) Margin
0.77% 16.17% 10.04% 31.76% -11.09% 20.70% 5.82% -20.38% 9.43% 0.87%
Tax Burden Percent
10.30% 71.64% 64.38% 166.29% 127.34% 91.81% 94.92% 100.27% 97.04% 86.43%
Interest Burden Percent
426.87% 131.48% 107.69% 95.64% 96.57% 107.18% 71.65% 138.04% 74.07% 16.40%
Effective Tax Rate
89.70% 28.36% 35.62% -66.29% 0.00% 8.19% 5.08% 0.00% 2.96% 13.57%
Return on Invested Capital (ROIC)
0.40% 31.07% 32.85% 104.75% -36.17% 88.37% 30.16% -54.40% 99.05% 587.53%
ROIC Less NNEP Spread (ROIC-NNEP)
-0.55% 26.50% 33.95% 105.88% -30.86% 84.15% 31.12% -34.34% 122.85% 687.36%
Return on Net Nonoperating Assets (RNNOA)
0.35% -18.57% -24.48% -75.02% 24.81% -68.62% -24.01% 23.85% -63.75% -572.94%
Return on Equity (ROE)
0.76% 12.50% 8.37% 29.73% -11.35% 19.76% 6.16% -30.55% 35.29% 14.59%
Cash Return on Invested Capital (CROIC)
33.38% -24.37% 50.77% 38.58% -79.99% 97.53% 15.37% -94.87% -52.68% -28.84%
Operating Return on Assets (OROA)
1.21% 10.05% 9.12% 14.04% -6.88% 14.96% 6.51% -11.48% 10.96% 5.11%
Return on Assets (ROA)
0.53% 9.47% 6.32% 22.33% -8.46% 14.72% 4.43% -15.89% 7.88% 0.72%
Return on Common Equity (ROCE)
0.76% 12.50% 8.37% 29.73% -11.35% 19.76% 6.16% -30.55% 35.29% 14.59%
Return on Equity Simple (ROE_SIMPLE)
0.95% 11.51% 7.80% 25.16% -11.32% 17.20% 5.69% -19.20% 24.85% 3.82%
Net Operating Profit after Tax (NOPAT)
6.32 445 373 974 -185 369 123 -170 141 44
NOPAT Margin
0.15% 12.03% 10.99% 32.62% -6.92% 17.10% 6.52% -11.09% 12.73% 5.81%
Net Nonoperating Expense Percent (NNEP)
0.96% 4.57% -1.10% -1.13% -5.31% 4.22% -0.96% -20.06% -23.80% -99.83%
Return On Investment Capital (ROIC_SIMPLE)
0.18% 8.50% 8.47% - - - - - - -
Cost of Revenue to Revenue
7.36% 6.90% 6.10% 5.06% 4.92% 5.29% 5.00% 5.17% 5.26% 3.58%
SG&A Expenses to Revenue
29.29% 31.42% 29.52% 24.77% 19.38% 21.71% 23.08% 23.84% 27.43% 26.08%
R&D to Revenue
61.46% 44.04% 46.72% 48.83% 83.10% 53.46% 63.66% 86.32% 52.62% 63.62%
Operating Expenses to Revenue
91.20% 76.31% 76.83% 75.33% 104.96% 76.09% 88.13% 110.67% 81.62% 89.70%
Earnings before Interest and Taxes (EBIT)
74 634 491 596 -240 454 161 -226 145 46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
163 717 559 654 -189 509 216 -174 203 91
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
3.86 2.71 4.09 4.30 7.29 7.24 7.03 12.26 45.03 117.86
Price to Tangible Book Value (P/TBV)
4.19 2.87 4.37 4.68 8.34 8.36 8.70 16.14 3,474.23 117.86
Price to Revenue (P/Rev)
3.14 3.81 5.26 5.43 7.14 8.71 7.19 13.01 17.08 26.76
Price to Earnings (P/E)
407.98 23.55 52.45 17.09 0.00 42.09 123.59 0.00 181.24 3,088.64
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.25% 4.25% 1.91% 5.85% 0.00% 2.38% 0.81% 0.00% 0.55% 0.03%
Enterprise Value to Invested Capital (EV/IC)
8.53 5.86 14.06 11.05 27.42 41.68 27.57 49.75 74.93 584.33
Enterprise Value to Revenue (EV/Rev)
2.63 2.90 4.28 4.58 6.40 7.69 6.40 12.19 16.93 26.58
Enterprise Value to EBITDA (EV/EBITDA)
68.34 14.93 25.99 20.91 0.00 32.65 55.77 0.00 92.02 220.27
Enterprise Value to EBIT (EV/EBIT)
150.57 16.88 29.58 22.94 0.00 36.57 74.81 0.00 129.10 434.87
Enterprise Value to NOPAT (EV/NOPAT)
1,766.89 24.09 38.96 14.05 0.00 45.00 98.18 0.00 133.04 457.61
Enterprise Value to Operating Cash Flow (EV/OCF)
33.31 21.57 14.98 18.25 0.00 23.37 35.82 0.00 61.42 224.08
Enterprise Value to Free Cash Flow (EV/FCFF)
21.33 0.00 25.21 38.14 0.00 40.78 192.68 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.01 0.01 0.01 0.01 0.01 0.02 0.03 0.03 1.60 3.62
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 1.55 3.62
Financial Leverage
-0.64 -0.70 -0.72 -0.71 -0.80 -0.82 -0.77 -0.69 -0.52 -0.83
Leverage Ratio
1.42 1.32 1.32 1.33 1.34 1.34 1.39 1.92 4.48 20.15
Compound Leverage Factor
6.04 1.74 1.43 1.27 1.30 1.44 1.00 2.65 3.32 3.30
Debt to Total Capital
1.13% 0.73% 0.83% 0.97% 1.45% 1.97% 2.49% 3.02% 61.53% 78.36%
Short-Term Debt to Total Capital
1.13% 0.73% 0.83% 0.97% 1.45% 1.97% 1.61% 2.04% 1.79% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.88% 0.99% 59.74% 78.36%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
98.87% 99.27% 99.17% 99.03% 98.55% 98.03% 97.51% 96.98% 38.47% 21.64%
Debt to EBITDA
0.24 0.05 0.07 0.06 -0.20 0.10 0.23 -0.29 3.30 6.82
Net Debt to EBITDA
-13.08 -4.69 -5.97 -3.87 10.53 -4.32 -6.90 7.21 -0.84 -1.51
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.08 -0.10 3.20 6.82
Debt to NOPAT
6.21 0.09 0.10 0.04 -0.21 0.14 0.40 -0.30 4.77 14.16
Net Debt to NOPAT
-338.18 -7.56 -8.94 -2.60 10.77 -5.96 -12.14 7.36 -1.21 -3.14
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.14 -0.10 4.63 14.16
Altman Z-Score
4.90 6.79 8.65 9.70 12.46 14.80 11.84 17.57 9.36 13.70
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.97 3.75 3.54 3.65 3.74 4.83 4.31 4.01 3.64 5.01
Quick Ratio
1.83 3.19 3.36 3.47 3.62 4.73 4.11 3.83 3.50 4.89
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
524 -349 577 359 -408 407 63 -297 -75 -9.89
Operating Cash Flow to CapEx
388.74% 1,528.31% 1,246.18% 414.07% -66.50% 910.35% 457.56% -83.76% 253.38% 343.84%
Free Cash Flow to Firm to Interest Expense
229.62 -136.66 216.28 188.00 -187.78 219.57 40.51 -4.81 -1.93 -0.22
Operating Cash Flow to Interest Expense
147.08 194.62 363.82 392.81 -57.31 383.10 217.90 -1.51 7.87 1.96
Operating Cash Flow Less CapEx to Interest Expense
109.24 181.89 334.62 297.95 -143.50 341.02 170.28 -3.30 4.76 1.39
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.69 0.59 0.63 0.70 0.76 0.71 0.76 0.78 0.84 0.84
Accounts Receivable Turnover
5.31 5.32 5.38 5.44 6.74 7.00 6.56 7.40 8.40 8.75
Inventory Turnover
5.12 4.86 5.92 6.81 9.44 12.44 14.00 15.01 19.76 25.20
Fixed Asset Turnover
5.60 4.96 4.64 4.65 5.69 6.19 6.49 7.19 8.72 8.98
Accounts Payable Turnover
2.03 1.32 0.92 1.11 1.44 1.22 1.10 1.11 1.10 0.99
Days Sales Outstanding (DSO)
68.71 68.56 67.80 67.12 54.12 52.11 55.66 49.31 43.44 41.74
Days Inventory Outstanding (DIO)
71.26 75.13 61.63 53.58 38.67 29.34 26.08 24.31 18.47 14.49
Days Payable Outstanding (DPO)
179.57 277.09 396.44 327.40 253.49 299.47 332.53 328.98 331.47 369.08
Cash Conversion Cycle (CCC)
-39.61 -133.40 -267.01 -206.70 -160.70 -218.02 -250.79 -255.36 -269.56 -312.86
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
1,310 1,827 1,034 1,238 622 399 437 377 250 34
Invested Capital Turnover
2.70 2.58 2.99 3.21 5.23 5.17 4.63 4.90 7.78 101.15
Increase / (Decrease) in Invested Capital
-517 793 -204 615 224 -38 60 127 216 54
Enterprise Value (EV)
11,169 10,709 14,533 13,681 17,061 16,609 12,043 18,733 18,719 20,034
Market Capitalization
13,306 14,072 17,869 16,213 19,048 18,808 13,532 19,987 18,889 20,172
Book Value per Share
$17.90 $23.16 $19.64 $17.07 $11.92 $12.06 $9.05 $7.73 $2.23 $0.92
Tangible Book Value per Share
$16.50 $21.91 $18.36 $15.68 $10.43 $10.44 $7.31 $5.87 $0.03 $0.92
Total Capital
3,487 5,228 4,407 3,807 2,650 2,651 1,975 1,681 1,090 791
Total Debt
39 38 37 37 38 52 49 51 671 620
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 17 17 651 620
Net Debt
-2,138 -3,363 -3,336 -2,532 -1,987 -2,200 -1,489 -1,254 -170 -138
Capital Expenditures (CapEx)
86 32 78 181 187 78 73 111 120 26
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-522 230 -267 -47 -34 -97 0.50 -5.95 -68 -34
Debt-free Net Working Capital (DFNWC)
1,636 3,443 2,972 2,301 1,767 2,020 1,439 1,164 740 674
Net Working Capital (NWC)
1,597 3,405 2,936 2,264 1,729 1,968 1,407 1,129 721 674
Net Nonoperating Expense (NNE)
-26 -153 32 25 111 -78 13 143 36 37
Net Nonoperating Obligations (NNO)
-2,138 -3,363 -3,336 -2,532 -1,989 -2,200 -1,489 -1,254 -170 -137
Total Depreciation and Amortization (D&A)
89 83 68 58 52 55 55 52 58 45
Debt-free, Cash-free Net Working Capital to Revenue
-12.30% 6.23% -7.86% -1.57% -1.29% -4.50% 0.03% -0.39% -6.18% -4.50%
Debt-free Net Working Capital to Revenue
38.58% 93.18% 87.56% 77.07% 66.27% 93.60% 76.46% 75.75% 66.94% 89.47%
Net Working Capital to Revenue
37.66% 92.14% 86.48% 75.83% 64.83% 91.17% 74.76% 73.52% 65.18% 89.47%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
$0.16 $2.67 $1.53 $4.30 ($1.36) $2.08 $0.52 ($1.53) $0.55 $0.04
Adjusted Weighted Average Basic Shares Outstanding
207.11M 223.63M 222.00M 220.43M 218.07M 214.91M 212.38M 204.58M 187.87M 179.60M
Adjusted Diluted Earnings per Share
$0.15 $2.65 $1.52 $4.27 ($1.36) $2.05 $0.51 ($1.53) $0.54 $0.03
Adjusted Weighted Average Diluted Shares Outstanding
210.53M 225.93M 223.96M 222.07M 218.07M 217.66M 215.64M 204.58M 194.13M 187.30M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
193.52M 224.53M 222.97M 221.33M 219.84M 216.78M 214.05M 211.66M 189.41M 187.20M
Normalized Net Operating Profit after Tax (NOPAT)
57 465 381 420 -168 387 148 -165 158 44
Normalized NOPAT Margin
1.34% 12.59% 11.22% 14.08% -6.31% 17.93% 7.84% -10.74% 14.25% 5.81%
Pre Tax Income Margin
7.47% 22.57% 15.59% 19.10% -8.71% 22.55% 6.13% -20.33% 9.71% 1.00%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
32.53 248.71 184.30 312.59 -110.61 244.85 104.33 -3.66 3.74 1.01
NOPAT to Interest Expense
2.77 174.25 139.93 510.52 -84.90 198.96 79.50 -2.76 3.63 0.96
EBIT Less CapEx to Interest Expense
-5.30 235.98 155.10 217.72 -196.80 202.76 56.71 -5.46 0.64 0.44
NOPAT Less CapEx to Interest Expense
-35.06 161.52 110.74 415.66 -171.09 156.88 31.87 -4.55 0.53 0.39
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
6,146.83% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Incyte

This table displays calculated financial ratios and metrics derived from Incyte's official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
19.53% 16.32% 23.81% 9.34% 8.93% 9.35% 11.63% 4.74% 10.29% 7.40% 1.27%
EBITDA Growth
110.72% 116.07% -31.74% -258.26% 106.35% 871.82% 69.57% -5.42% -42.75% -109.97% -33.91%
EBIT Growth
137.30% 146.70% -34.78% -281.17% 137.05% 353.24% 74.18% -7.26% -51.07% -126.89% -36.85%
NOPAT Growth
110.07% 39.15% -36.83% -335.56% 536.43% 461.60% 49.76% -20.65% -83.48% -95.24% -48.58%
Net Income Growth
-6.69% 0.07% -37.84% -318.43% 681.22% 606.51% 51.87% 26.09% -42.87% -94.95% -37.95%
EPS Growth
6.67% 1.12% -28.95% -326.67% 650.00% 584.62% 52.00% 25.00% -41.18% -94.88% -39.02%
Operating Cash Flow Growth
21.60% 158.05% 110.28% -287.77% 307.20% -47.92% -50.12% 76.01% -148.95% 145.91% 16.18%
Free Cash Flow Firm Growth
347.30% 208.62% -78.40% -408.88% 148.86% -386.56% 98.21% 151.87% 87.90% 339.92% 30.78%
Invested Capital Growth
-0.47% -28.31% 8.33% 25.38% 2.61% 76.71% 14.06% -5.10% 6.32% -16.45% 64.09%
Revenue Q/Q Growth
-10.67% 3.59% 9.02% 18.49% -13.07% 10.26% -3.73% 18.05% -12.74% 12.56% -9.67%
EBITDA Q/Q Growth
7.91% 13.25% 147.45% -356.21% -38.88% -64.22% 10.02% 234.07% -33.14% -107.86% -38.64%
EBIT Q/Q Growth
9.02% 14.88% 139.75% -413.49% -42.52% -69.63% 10.42% 310.19% -40.41% -120.89% -41.21%
NOPAT Q/Q Growth
-28.33% 94.63% 129.69% -607.28% -52.53% -11.64% 10.70% 1,270.58% -58.11% -76.44% -41.35%
Net Income Q/Q Growth
-21.38% 89.01% 123.94% -362.23% -15.68% 17.41% -15.86% 837.88% -23.74% -74.76% -30.14%
EPS Q/Q Growth
-11.11% 66.67% 126.47% -372.00% -15.73% 17.11% -15.56% 800.00% -23.08% -74.00% -30.56%
Operating Cash Flow Q/Q Growth
-30.21% 22.63% 154.01% -363.04% 48.12% -0.07% -51.77% 390.26% -137.23% -4.29% 70.18%
Free Cash Flow Firm Q/Q Growth
-79.62% 6,465.65% 98.24% -2,062.49% 115.31% -10,354.65% -103.04% 410.45% -129.02% 165.33% 11.88%
Invested Capital Q/Q Growth
0.45% -8.87% -3.21% 12.34% -4.51% 37.69% 12.03% -8.06% 24.60% -11.13% -6.78%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
93.05% 92.49% 92.44% 92.66% 93.08% 93.12% 93.46% 92.84% 92.97% 93.62% 93.37%
EBITDA Margin
22.38% 18.52% 16.94% -38.93% 18.00% 9.97% 30.74% 26.90% 9.50% -1.41% 20.23%
Operating Margin
19.49% 25.58% 12.84% -45.81% 10.43% 18.48% 23.36% 20.30% 3.06% 7.56% 16.81%
EBIT Margin
20.26% 16.60% 14.96% -41.04% 15.51% 7.82% 28.41% 24.77% 7.13% -3.38% 18.21%
Profit (Net Income) Margin
15.03% 17.07% 9.36% -42.60% 19.25% 19.84% 18.64% 21.32% 2.68% 3.07% 13.70%
Tax Burden Percent
67.55% 64.14% 68.01% 114.07% 71.79% 74.21% 73.25% 73.32% 41.85% 35.30% 75.90%
Interest Burden Percent
109.81% 160.38% 91.92% 90.99% 172.83% 341.72% 89.55% 117.41% 89.96% -257.47% 99.13%
Effective Tax Rate
32.45% 35.86% 31.99% 0.00% 28.21% 25.79% 26.75% 26.68% 58.15% 64.70% 24.10%
Return on Invested Capital (ROIC)
44.05% 44.36% 25.75% -92.65% 21.62% 35.43% 49.60% 42.99% 3.56% 7.98% 45.38%
ROIC Less NNEP Spread (ROIC-NNEP)
43.44% 44.08% 25.48% -88.32% 18.76% 33.57% 49.18% 41.07% 3.17% 7.85% 45.10%
Return on Net Nonoperating Assets (RNNOA)
-30.79% -28.07% -16.79% 57.85% -13.79% -23.53% -35.81% -29.75% -2.22% -5.66% -33.65%
Return on Equity (ROE)
13.25% 16.29% 8.96% -34.81% 7.83% 11.90% 13.79% 13.24% 1.34% 2.32% 11.73%
Cash Return on Invested Capital (CROIC)
1.37% 33.38% -8.45% -22.20% 35.99% -24.37% 13.55% 28.26% 18.66% 50.77% 53.52%
Operating Return on Assets (OROA)
13.88% 11.51% 10.70% -29.12% 9.04% 4.58% 17.23% 15.10% 4.56% -2.13% 12.49%
Return on Assets (ROA)
10.29% 11.84% 6.69% -30.23% 11.21% 11.62% 11.31% 13.00% 1.72% 1.94% 9.40%
Return on Common Equity (ROCE)
13.25% 16.29% 8.96% -34.81% 7.83% 11.90% 13.79% 13.24% 1.34% 2.32% 11.73%
Return on Equity Simple (ROE_SIMPLE)
0.58% 0.00% 1.02% 3.25% 13.82% 0.00% 8.62% 7.73% 7.27% 0.00% 20.73%
Net Operating Profit after Tax (NOPAT)
139 193 99 -335 66 139 157 142 10 25 105
NOPAT Margin
13.16% 16.41% 8.73% -32.07% 7.49% 13.71% 17.11% 14.88% 1.28% 2.67% 12.76%
Net Nonoperating Expense Percent (NNEP)
0.61% 0.28% 0.27% -4.34% 2.86% 1.85% 0.42% 1.92% 0.39% 0.13% 0.28%
Return On Investment Capital (ROIC_SIMPLE)
3.70% 5.55% - - - 2.66% - - - 0.56% -
Cost of Revenue to Revenue
6.95% 7.51% 7.56% 7.34% 6.92% 6.88% 6.54% 7.16% 7.03% 6.38% 6.63%
SG&A Expenses to Revenue
30.93% 27.72% 27.17% 29.32% 34.09% 29.00% 29.15% 29.74% 39.03% 29.44% 32.36%
R&D to Revenue
41.53% 39.54% 50.37% 109.07% 48.73% 43.86% 40.88% 41.98% 50.29% 54.10% 46.64%
Operating Expenses to Revenue
73.56% 66.91% 79.60% 138.47% 82.65% 74.64% 70.10% 72.54% 89.91% 86.05% 76.56%
Earnings before Interest and Taxes (EBIT)
213 196 170 -428 137 79 261 236 58 -31 150
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
236 218 193 -406 159 101 282 257 77 -13 167
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.20 3.86 4.01 4.54 0.00 2.71 2.63 2.93 3.61 4.09 3.51
Price to Tangible Book Value (P/TBV)
3.44 4.19 4.40 4.99 0.00 2.87 2.79 3.12 3.87 4.37 3.77
Price to Revenue (P/Rev)
2.66 3.14 3.12 3.53 0.00 3.81 3.59 3.95 4.64 5.26 4.45
Price to Earnings (P/E)
550.91 407.98 391.93 139.90 0.00 23.55 30.46 37.89 49.68 52.45 16.92
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.18% 0.25% 0.26% 0.71% 0.00% 4.25% 3.28% 2.64% 2.01% 1.91% 5.91%
Enterprise Value to Invested Capital (EV/IC)
7.12 8.53 7.65 8.15 0.00 5.86 7.04 8.72 10.04 14.06 10.11
Enterprise Value to Revenue (EV/Rev)
2.12 2.63 2.70 3.14 0.00 2.90 2.59 2.94 3.73 4.28 3.53
Enterprise Value to EBITDA (EV/EBITDA)
32.61 68.34 53.76 41.13 0.00 14.93 12.78 16.80 20.54 25.99 16.71
Enterprise Value to EBIT (EV/EBIT)
47.41 150.57 94.58 58.44 0.00 16.88 14.33 19.11 23.14 29.58 18.40
Enterprise Value to NOPAT (EV/NOPAT)
793.42 1,766.89 0.00 2,773.80 0.00 24.09 28.12 36.88 41.75 38.96 12.31
Enterprise Value to Operating Cash Flow (EV/OCF)
24.48 33.31 107.98 0.00 0.00 21.57 14.77 13.23 19.95 14.98 14.67
Enterprise Value to Free Cash Flow (EV/FCFF)
519.86 21.33 0.00 0.00 0.00 0.00 55.37 30.06 55.47 25.21 23.47
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.02 0.01 0.02 0.01 0.01 0.01 0.01 0.01 0.02 0.01 0.02
Long-Term Debt to Equity
0.01 0.00 0.01 0.00 0.01 0.00 0.01 0.00 0.01 0.00 0.01
Financial Leverage
-0.71 -0.64 -0.66 -0.66 -0.74 -0.70 -0.73 -0.72 -0.70 -0.72 -0.75
Leverage Ratio
1.42 1.42 1.41 1.40 1.31 1.32 1.30 1.31 1.30 1.32 1.32
Compound Leverage Factor
1.56 2.27 1.29 1.28 2.27 4.51 1.16 1.53 1.17 -3.41 1.31
Debt to Total Capital
1.99% 1.13% 2.12% 1.22% 1.21% 0.73% 1.31% 0.79% 1.48% 0.83% 1.51%
Short-Term Debt to Total Capital
1.11% 1.13% 1.25% 1.22% 0.68% 0.73% 0.74% 0.79% 0.82% 0.83% 0.80%
Long-Term Debt to Total Capital
0.87% 0.00% 0.87% 0.00% 0.53% 0.00% 0.58% 0.00% 0.66% 0.00% 0.71%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
98.01% 98.87% 97.88% 98.78% 98.79% 99.27% 98.69% 99.22% 98.52% 99.17% 98.49%
Debt to EBITDA
0.26 0.24 0.34 0.13 0.07 0.05 0.09 0.06 0.11 0.07 0.09
Net Debt to EBITDA
-8.19 -13.08 -8.48 -5.14 -4.25 -4.69 -4.93 -5.78 -5.04 -5.97 -4.35
Long-Term Debt to EBITDA
0.11 0.00 0.14 0.00 0.03 0.00 0.04 0.00 0.05 0.00 0.04
Debt to NOPAT
6.30 6.21 -10.93 8.52 0.13 0.09 0.20 0.13 0.22 0.10 0.07
Net Debt to NOPAT
-199.22 -338.18 276.44 -346.59 -8.09 -7.56 -10.85 -12.69 -10.24 -8.94 -3.21
Long-Term Debt to NOPAT
2.77 0.00 -4.50 0.00 0.06 0.00 0.09 0.00 0.10 0.00 0.03
Altman Z-Score
4.42 4.97 5.03 5.33 0.00 6.52 6.64 6.93 8.39 8.35 8.12
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.04 1.97 1.87 1.92 3.47 3.75 3.91 3.81 3.95 3.54 3.80
Quick Ratio
1.88 1.83 1.69 1.69 3.29 3.19 3.71 3.63 3.71 3.36 3.57
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
145 711 -11 -635 32 -654 -6.26 206 -66 228 -349
Operating Cash Flow to CapEx
8,395.93% 2,192.92% 5,993.27% -1,063.04% 2,291.45% 6,516.50% 1,346.89% 4,177.81% -886.97% 1,333.44% 1,065.70%
Free Cash Flow to Firm to Interest Expense
219.41 1,695.91 -14.42 -967.04 75.29 -813.65 -10.04 314.03 -141.27 342.25 -545.11
Operating Cash Flow to Interest Expense
403.13 909.83 401.64 -876.05 508.86 183.74 237.30 467.98 -225.17 425.28 462.37
Operating Cash Flow Less CapEx to Interest Expense
398.33 868.34 394.94 -958.46 486.66 180.92 219.68 456.78 -250.55 393.39 418.99
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.69 0.69 0.72 0.71 0.58 0.59 0.61 0.61 0.64 0.63 0.69
Accounts Receivable Turnover
5.63 5.31 5.76 5.60 5.50 5.32 5.66 5.32 5.85 5.38 5.87
Inventory Turnover
5.08 5.12 4.60 3.91 4.96 4.86 4.74 5.28 5.80 5.92 5.71
Fixed Asset Turnover
5.94 5.60 5.41 5.10 5.16 4.96 4.98 4.78 4.72 4.64 4.75
Accounts Payable Turnover
1.80 2.03 1.84 1.76 2.36 1.32 1.62 1.36 2.13 0.92 1.38
Days Sales Outstanding (DSO)
64.87 68.71 63.39 65.16 66.32 68.56 64.50 68.62 62.38 67.80 62.18
Days Inventory Outstanding (DIO)
71.82 71.26 79.41 93.25 73.61 75.13 76.96 69.09 62.98 61.63 63.95
Days Payable Outstanding (DPO)
202.46 179.57 197.92 207.26 154.85 277.09 225.95 267.61 171.75 396.44 264.35
Cash Conversion Cycle (CCC)
-65.78 -39.61 -55.12 -48.86 -14.92 -133.40 -84.49 -129.90 -46.40 -267.01 -138.22
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
1,316 1,310 1,438 1,485 1,322 1,827 1,327 1,185 1,288 1,034 1,163
Invested Capital Turnover
3.35 2.70 2.95 2.89 2.89 2.58 2.90 2.89 2.78 2.99 3.56
Increase / (Decrease) in Invested Capital
-6.21 -517 111 301 34 793 164 -64 77 -204 454
Enterprise Value (EV)
9,366 11,169 10,997 12,100 0.00 10,709 9,341 10,331 12,940 14,533 11,760
Market Capitalization
11,718 13,306 12,731 13,612 0.00 14,072 12,946 13,887 16,114 17,869 14,823
Book Value per Share
$18.95 $17.90 $16.47 $13.35 $24.03 $23.16 $22.01 $21.25 $20.01 $19.64 $19.00
Tangible Book Value per Share
$17.59 $16.50 $15.03 $12.15 $22.81 $21.91 $20.74 $19.95 $18.69 $18.36 $17.70
Total Capital
3,742 3,487 3,240 3,034 5,460 5,228 4,997 4,778 4,529 4,407 4,291
Total Debt
74 39 69 37 66 38 66 38 67 37 65
Total Long-Term Debt
33 0.00 28 0.00 29 0.00 29 0.00 30 0.00 30
Net Debt
-2,352 -2,138 -1,734 -1,512 -4,072 -3,363 -3,604 -3,556 -3,174 -3,336 -3,063
Capital Expenditures (CapEx)
3.17 17 5.19 54 9.55 2.27 11 7.34 12 21 28
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-580 -522 -427 -252 -361 230 -202 -240 -110 -267 -128
Debt-free Net Working Capital (DFNWC)
1,829 1,636 1,347 1,267 3,490 3,443 3,315 3,183 3,003 2,972 2,849
Net Working Capital (NWC)
1,787 1,597 1,307 1,230 3,453 3,405 3,278 3,146 2,966 2,936 2,815
Net Nonoperating Expense (NNE)
-20 -7.83 -7.10 110 -104 -62 -14 -61 -11 -3.71 -7.75
Net Nonoperating Obligations (NNO)
-2,352 -2,138 -1,734 -1,512 -4,072 -3,363 -3,604 -3,556 -3,174 -3,336 -3,063
Total Depreciation and Amortization (D&A)
22 23 23 22 22 22 21 20 19 18 17
Debt-free, Cash-free Net Working Capital to Revenue
-13.14% -12.30% -10.48% -6.54% -9.58% 6.23% -5.59% -6.84% -3.17% -7.86% -3.86%
Debt-free Net Working Capital to Revenue
41.44% 38.58% 33.06% 32.85% 92.62% 93.18% 91.85% 90.60% 86.53% 87.56% 85.53%
Net Working Capital to Revenue
40.49% 37.66% 32.07% 31.89% 91.63% 92.14% 90.83% 89.54% 85.46% 86.48% 84.50%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.82 $0.89 $0.55 ($2.04) $0.76 $0.90 $0.76 $0.91 $0.10 $0.12 $0.51
Adjusted Weighted Average Basic Shares Outstanding
193.71M 207.11M 192.63M 218.18M 224.48M 223.63M 224.08M 223.25M 222.96M 222.00M 222.42M
Adjusted Diluted Earnings per Share
$0.80 $0.90 $0.54 ($2.04) $0.75 $0.89 $0.76 $0.90 $0.10 $0.13 $0.50
Adjusted Weighted Average Diluted Shares Outstanding
198.20M 210.53M 195.84M 218.18M 227.22M 225.93M 226.17M 225.65M 225.59M 223.96M 224.18M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
193.57M 193.52M 192.65M 192.60M 224.54M 224.53M 224.11M 224.09M 223.09M 222.97M 222.48M
Normalized Net Operating Profit after Tax (NOPAT)
146 191 115 -334 66 150 157 148 22 66 88
Normalized NOPAT Margin
13.91% 16.19% 10.13% -32.01% 7.45% 14.82% 17.08% 15.53% 2.68% 7.13% 10.74%
Pre Tax Income Margin
22.24% 26.62% 13.76% -37.34% 26.81% 26.74% 25.44% 29.08% 6.41% 8.70% 18.05%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
323.13 466.86 220.00 -652.00 317.77 98.62 419.06 360.99 122.91 -46.94 233.84
NOPAT to Interest Expense
210.00 461.53 128.37 -509.42 153.44 172.85 252.46 216.92 22.10 37.10 163.84
EBIT Less CapEx to Interest Expense
318.33 425.37 213.30 -734.40 295.57 95.80 401.44 349.79 97.52 -78.84 190.45
NOPAT Less CapEx to Interest Expense
205.20 420.04 121.67 -591.83 131.23 170.03 234.84 205.72 -3.28 5.21 120.46
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 6,146.83% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Incyte's Financials

When does Incyte's financial year end?

According to the most recent income statement we have on file, Incyte's fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Incyte's net income changed over the last 9 years?

Incyte's net income appears to be on an upward trend, with a most recent value of $32.62 million in 2024, rising from $6.53 million in 2015. The previous period was $597.60 million in 2023. View Incyte's forecast to see where analysts expect Incyte to go next.

What is Incyte's operating income?
Incyte's total operating income in 2024 was $61.37 million, based on the following breakdown:
  • Total Gross Profit: $3.93 billion
  • Total Operating Expenses: $3.87 billion
How has Incyte revenue changed over the last 9 years?

Over the last 9 years, Incyte's total revenue changed from $753.75 million in 2015 to $4.24 billion in 2024, a change of 462.7%.

How much debt does Incyte have?

Incyte's total liabilities were at $2.00 billion at the end of 2024, a 25.4% increase from 2023, and a 138.8% increase since 2015.

How much cash does Incyte have?

In the past 9 years, Incyte's cash and equivalents has ranged from $521.44 million in 2015 to $3.21 billion in 2023, and is currently $1.69 billion as of their latest financial filing in 2024.

How has Incyte's book value per share changed over the last 9 years?

Over the last 9 years, Incyte's book value per share changed from 0.92 in 2015 to 17.90 in 2024, a change of 1,844.8%.



This page (NASDAQ:INCY) was last updated on 5/27/2025 by MarketBeat.com Staff
From Our Partners